Dialysis showdown: which type helps kidney patients live longer?
NCT ID NCT01413074
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared survival in people with end-stage kidney disease who were randomly assigned to either peritoneal dialysis or hemodialysis. The goal was to see which type of dialysis leads to longer life and fewer complications. The study was conducted in China and was terminated early, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Peritoneal dialysis and hemodialysis
- What this could lead to
- If successful, this could help doctors choose the best dialysis type for patients with kidney failure.
- What could go wrong
- The study was terminated early, so results may be incomplete. It only included patients in China, so findings may not apply elsewhere.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hangzhou Hospital of Tranditional Chinese Medicine
Hangzhou, Zhejiang, 310007, China
-
Huashan Hospital ,Fudan University
Shanghai, Shanghai Municipality, 200040, China
-
Renji Hospital , Shanghai Jiaotong University , School of Medicine
Shanghai, Shanghai Municipality, China
-
Ruijin Hospital,Shanghai Jiaotong University , School of Medicine
Shanghai, Shanghai Municipality, 200025, China
-
Shanghai Changzheng Hospital
Shanghai, Shanghai Municipality, 200003, China
-
The First Affiliated Hospital , Sun Yet-Sen University
Guangzhou, Guangdong, 510080, China
-
The First Affiliated Hospital , Zhejiang University, School of Medicine
Hangzhou, Zhejiang, 310003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
- Can a new drug combo help kidney transplants last longer?
- Ultrasound may fine-tune fluid balance in dialysis patients — a trial puts it to the test
- Dialysis patients may straighten up with In-Chair exercise
- New nerve block may cut opioid use after kidney transplants
- Could pumpkin seed oil ease inflammation in dialysis patients?